enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. Empagliflozin - Wikipedia

    en.wikipedia.org/wiki/Empagliflozin

    In clinical trials, participants with type 2 diabetes taking empagliflozin with other diabetic medications lost an average of 2% of their baseline body weight. [55] [56] A higher percentage of people taking empagliflozin achieved weight loss greater than 5% from their baseline, which has been associated with improved glucose control.

  3. Empagliflozin/linagliptin/metformin - Wikipedia

    en.wikipedia.org/wiki/Empagliflozin/linagliptin/...

    To reduce the risk of developing ketoacidosis (a serious condition where the body produces high levels of blood acids called ketones) after surgery, the FDA has approved changes to the prescribing information for SGLT2 inhibitor diabetes medications, recommending they be temporarily stopped before scheduled surgery.

  4. Lilly, Boehringer say Jardiance slows kidney disease ... - AOL

    www.aol.com/news/lilly-boehringer-jardiance...

    In a statement on Friday, the two partners said Jardiance cut the risk of kidney disease progression and cardiovascular death by 28%, citing results from a late-stage trial which included people ...

  5. Can Weight Loss Drugs Make You Boring? Doctors Explain ...

    www.aol.com/lifestyle/weight-loss-drugs-boring...

    Reassuring news: Doctors have an idea about why you may notice personality changes after going on a weight loss drug, and if it sounds like something you’re going through, there’s something ...

  6. 12 reasons you aren't losing weight even though you're eating ...

    www.aol.com/12-reasons-arent-losing-weight...

    Another theory is that your basal metabolic rate—the calories your body burns at rest—drops as you lose weight. This shift can shrink your calorie deficit, making it harder to shed pounds.

  7. SGLT2 inhibitor - Wikipedia

    en.wikipedia.org/wiki/SGLT2_inhibitor

    Dapagliflozin disposition is not evidently affected by body mass index (BMI) or body weight, therefore the pharmacokinetic findings are expected to be applicable to patients with a higher BMI. Dapagliflozin resulted in dose-dependent increases excretions in urinary glucose, up to 47g/d following single-dose administration, which can be expected ...

  8. Anti-obesity medication - Wikipedia

    en.wikipedia.org/wiki/Anti-obesity_medication

    Anti-obesity medication or weight loss medications are pharmacological agents that reduce or control excess body fat. These medications alter one of the fundamental processes of the human body , weight regulation, by: reducing appetite and consequently energy intake , increasing energy expenditure , redirecting nutrients from adipose to lean ...

  9. How to answer questions about your body this holiday season ...

    www.aol.com/answer-questions-body-holiday-season...

    Or, if you aren't on a weight loss journey or don't wish to entertain conversations about your body, remind yourself that your body is yours—and yours alone. Know your boundaries.